Υδροξυκαρβαμίδιο (Greek Wikipedia)

Analysis of information sources in references of the Wikipedia article "Υδροξυκαρβαμίδιο" in Greek language version.

refsWebsite

Global rank Greek rank

14nih.gov

4^th place

10doi.org

2^nd place

3^rd place

4web.archive.org

1^st place

2archive.org

6^th place

5^th place

1medicines.org.uk

3,823^rd place

2,141^st place

1drugs.com

399^th place

130^th place

1who.int

195^th place

72^nd place

1msh.org

low place

8,713^th place

1galinos.gr

low place

994^th place

1worldcat.org

5^th place

8^th place

1nejm.org

2,374^th place

2,218^th place

1ijdvl.com

low place

1jci.org

low place

1jbc.org

4,455^th place

4,017^th place

archive.org

Escribano, L.; Álvarez-Twose, I. N.; Sánchez-Muñoz, L.; Garcia-Montero, A.; Núñez, R.; Almeida, J.; Jara-Acevedo, M.; Teodósio, C. και άλλοι. (2009). «Prognosis in adult indolent systemic mastocytosis: A long-term study of the Spanish Network on Mastocytosis in a series of 145 patients». Journal of Allergy and Clinical Immunology 124 (3): 514–521. doi:10.1016/j.jaci.2009.05.003. PMID 19541349. https://archive.org/details/sim_journal-of-allergy-and-clinical-immunology_2009-09_124_3/page/514.
Longe, Jacqueline L. (2002). Gale Encyclopedia Of Cancer: A Guide To Cancer And Its Treatments. Detroit: Thomson Gale. σελίδες 514–516. ISBN 978-1-4144-0362-5.

doi.org

dx.doi.org

Kettani, Tayeb; Cotton, Frédéric; Gulbis, Béatrice; Ferster, Alina; Kumps, Alain (2009-02-01). «Plasma hydroxyurea determined by gas chromatography-mass spectrometry». Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences 877 (4): 446–450. doi:10.1016/j.jchromb.2008.12.048. ISSN 1570-0232. PMID 19144580. https://www.ncbi.nlm.nih.gov/pubmed/19144580.
«Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia». N. Engl. J. Med. 353 (1): 33–45. July 2005. doi:10.1056/NEJMoa043800. PMID 16000354. http://content.nejm.org/cgi/pmidlookup?view=short&pmid=16000354&promo=ONFLNS19.
«Systematic review: Hydroxyurea for the treatment of adults with sickle cell disease». Ann. Intern. Med. 148 (12): 939–55. June 2008. doi:10.7326/0003-4819-148-12-200806170-00221. PMID 18458272.
Rustin, MH (November 2012). «Long-term safety of biologics in the treatment of moderate-to-severe plaque psoriasis: review of current data». Br J Dermatol 167 (Suppl 3): 3–11. doi:10.1111/j.1365-2133.2012.11208.x. PMID 23082810.
Escribano, L.; Álvarez-Twose, I. N.; Sánchez-Muñoz, L.; Garcia-Montero, A.; Núñez, R.; Almeida, J.; Jara-Acevedo, M.; Teodósio, C. και άλλοι. (2009). «Prognosis in adult indolent systemic mastocytosis: A long-term study of the Spanish Network on Mastocytosis in a series of 145 patients». Journal of Allergy and Clinical Immunology 124 (3): 514–521. doi:10.1016/j.jaci.2009.05.003. PMID 19541349. https://archive.org/details/sim_journal-of-allergy-and-clinical-immunology_2009-09_124_3/page/514.
Liebelt, E.; Balk, S.; Faber, W.; Fisher, J.; Hughes, C.; Lanzkron, S.; Lewis, K.; Marchetti, F. και άλλοι. (2007). «NTP-CERHR expert panel report on the reproductive and developmental toxicity of hydroxyurea». Birth defects research. Part B, Developmental and reproductive toxicology 80 (4): 259–366. doi:10.1002/bdrb.20123. PMID 17712860.
Platt OS (2008). «Hydroxyurea for the treatment of sickle cell anemia». N. Engl. J. Med. 358 (13): 1362–9. doi:10.1056/NEJMct0708272. PMID 18367739.
Platt OS (2008). «Hydroxyurea for the treatment of sickle cell anemia». N. Engl. J. Med. 358 (13): 1362–9. doi:10.1056/NEJMct0708272. PMID 18367739.
«Hydroxyurea induces fetal hemoglobin by the nitric oxide-dependent activation of soluble guanylyl cyclase». J Clin Invest 111 (2): 231–9. 2003. doi:10.1172/JCI16672. PMID 12531879. PMC 151872. http://www.jci.org/articles/view/16672.
«Hydroxyurea arrests DNA replication by a mechanism that preserves basal dNTP pools». J. Biol. Chem. 279 (1): 223–30. January 2004. doi:10.1074/jbc.M303952200. PMID 14573610. Αρχειοθετήθηκε από το πρωτότυπο στις 2023-10-11. https://web.archive.org/web/20231011233407/https://www.jbc.org/article/S0021-9258(18)52807-6/fulltext. Ανακτήθηκε στις 2017-02-07.

drugs.com

«Hydroxyurea». The American Society of Health-System Pharmacists. Ανακτήθηκε στις 8 Δεκεμβρίου 2016.

galinos.gr

«Γαληνός - Δραστική ουσία - Υδροξυκαρβαμίδη - Διάθεση». www.galinos.gr. Ανακτήθηκε στις 18 Απριλίου 2020.

ijdvl.com

«Hydroxyurea as an alternative therapy for psoriasis». Indian J Dermatol Venereol Leprol 70 (1): 13–7. 2004. PMID 17642550. Αρχειοθετήθηκε από το πρωτότυπο στις 2009-07-03. https://web.archive.org/web/20090703155748/http://www.ijdvl.com/article.asp?issn=0378-6323%3Byear%3D2004%3Bvolume%3D70%3Bissue%3D1%3Bspage%3D13%3Bepage%3D17%3Baulast%3DSharma. Ανακτήθηκε στις 2017-02-07.

jbc.org

«Hydroxyurea arrests DNA replication by a mechanism that preserves basal dNTP pools». J. Biol. Chem. 279 (1): 223–30. January 2004. doi:10.1074/jbc.M303952200. PMID 14573610. Αρχειοθετήθηκε από το πρωτότυπο στις 2023-10-11. https://web.archive.org/web/20231011233407/https://www.jbc.org/article/S0021-9258(18)52807-6/fulltext. Ανακτήθηκε στις 2017-02-07.

jci.org

«Hydroxyurea induces fetal hemoglobin by the nitric oxide-dependent activation of soluble guanylyl cyclase». J Clin Invest 111 (2): 231–9. 2003. doi:10.1172/JCI16672. PMID 12531879. PMC 151872. http://www.jci.org/articles/view/16672.

medicines.org.uk

«Hydrea 500 mg Hard Capsules - Summary of Product Characteristics (SPC) - (eMC)». www.medicines.org.uk. Αρχειοθετήθηκε από το πρωτότυπο στις 20 Δεκεμβρίου 2016. Ανακτήθηκε στις 14 Δεκεμβρίου 2016.

msh.org

erc.msh.org

«Hydroxycarbamide». International Drug Price Indicator Guide. Ανακτήθηκε στις 8 Δεκεμβρίου 2016. ^{[νεκρός σύνδεσμος]}

nejm.org

content.nejm.org

«Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia». N. Engl. J. Med. 353 (1): 33–45. July 2005. doi:10.1056/NEJMoa043800. PMID 16000354. http://content.nejm.org/cgi/pmidlookup?view=short&pmid=16000354&promo=ONFLNS19.

nih.gov

ncbi.nlm.nih.gov

Kettani, Tayeb; Cotton, Frédéric; Gulbis, Béatrice; Ferster, Alina; Kumps, Alain (2009-02-01). «Plasma hydroxyurea determined by gas chromatography-mass spectrometry». Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences 877 (4): 446–450. doi:10.1016/j.jchromb.2008.12.048. ISSN 1570-0232. PMID 19144580. https://www.ncbi.nlm.nih.gov/pubmed/19144580.
«Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia». N. Engl. J. Med. 353 (1): 33–45. July 2005. doi:10.1056/NEJMoa043800. PMID 16000354. http://content.nejm.org/cgi/pmidlookup?view=short&pmid=16000354&promo=ONFLNS19.
«Systematic review: Hydroxyurea for the treatment of adults with sickle cell disease». Ann. Intern. Med. 148 (12): 939–55. June 2008. doi:10.7326/0003-4819-148-12-200806170-00221. PMID 18458272.
«Hydroxyurea as an alternative therapy for psoriasis». Indian J Dermatol Venereol Leprol 70 (1): 13–7. 2004. PMID 17642550. Αρχειοθετήθηκε από το πρωτότυπο στις 2009-07-03. https://web.archive.org/web/20090703155748/http://www.ijdvl.com/article.asp?issn=0378-6323%3Byear%3D2004%3Bvolume%3D70%3Bissue%3D1%3Bspage%3D13%3Bepage%3D17%3Baulast%3DSharma. Ανακτήθηκε στις 2017-02-07.
Rustin, MH (November 2012). «Long-term safety of biologics in the treatment of moderate-to-severe plaque psoriasis: review of current data». Br J Dermatol 167 (Suppl 3): 3–11. doi:10.1111/j.1365-2133.2012.11208.x. PMID 23082810.
Escribano, L.; Álvarez-Twose, I. N.; Sánchez-Muñoz, L.; Garcia-Montero, A.; Núñez, R.; Almeida, J.; Jara-Acevedo, M.; Teodósio, C. και άλλοι. (2009). «Prognosis in adult indolent systemic mastocytosis: A long-term study of the Spanish Network on Mastocytosis in a series of 145 patients». Journal of Allergy and Clinical Immunology 124 (3): 514–521. doi:10.1016/j.jaci.2009.05.003. PMID 19541349. https://archive.org/details/sim_journal-of-allergy-and-clinical-immunology_2009-09_124_3/page/514.
Dalziel, K.; Round, A.; Stein, K.; Garside, R.; Price, A. (2004). «Effectiveness and cost-effectiveness of imatinib for first-line treatment of chronic myeloid leukaemia in chronic phase: A systematic review and economic analysis». Health technology assessment (Winchester, England) 8 (28): iii, ii1–120. PMID 15245690.
Liebelt, E.; Balk, S.; Faber, W.; Fisher, J.; Hughes, C.; Lanzkron, S.; Lewis, K.; Marchetti, F. και άλλοι. (2007). «NTP-CERHR expert panel report on the reproductive and developmental toxicity of hydroxyurea». Birth defects research. Part B, Developmental and reproductive toxicology 80 (4): 259–366. doi:10.1002/bdrb.20123. PMID 17712860.
Platt OS (2008). «Hydroxyurea for the treatment of sickle cell anemia». N. Engl. J. Med. 358 (13): 1362–9. doi:10.1056/NEJMct0708272. PMID 18367739.
Platt OS (2008). «Hydroxyurea for the treatment of sickle cell anemia». N. Engl. J. Med. 358 (13): 1362–9. doi:10.1056/NEJMct0708272. PMID 18367739.
«Hydroxyurea induces fetal hemoglobin by the nitric oxide-dependent activation of soluble guanylyl cyclase». J Clin Invest 111 (2): 231–9. 2003. doi:10.1172/JCI16672. PMID 12531879. PMC 151872. http://www.jci.org/articles/view/16672.
«Hydroxyurea arrests DNA replication by a mechanism that preserves basal dNTP pools». J. Biol. Chem. 279 (1): 223–30. January 2004. doi:10.1074/jbc.M303952200. PMID 14573610. Αρχειοθετήθηκε από το πρωτότυπο στις 2023-10-11. https://web.archive.org/web/20231011233407/https://www.jbc.org/article/S0021-9258(18)52807-6/fulltext. Ανακτήθηκε στις 2017-02-07.

pubmedcentral.nih.gov

«Systematic review: Hydroxyurea for the treatment of adults with sickle cell disease». Ann. Intern. Med. 148 (12): 939–55. June 2008. doi:10.7326/0003-4819-148-12-200806170-00221. PMID 18458272.
«Hydroxyurea induces fetal hemoglobin by the nitric oxide-dependent activation of soluble guanylyl cyclase». J Clin Invest 111 (2): 231–9. 2003. doi:10.1172/JCI16672. PMID 12531879. PMC 151872. http://www.jci.org/articles/view/16672.

web.archive.org

«Hydrea 500 mg Hard Capsules - Summary of Product Characteristics (SPC) - (eMC)». www.medicines.org.uk. Αρχειοθετήθηκε από το πρωτότυπο στις 20 Δεκεμβρίου 2016. Ανακτήθηκε στις 14 Δεκεμβρίου 2016.
«Hydroxyurea as an alternative therapy for psoriasis». Indian J Dermatol Venereol Leprol 70 (1): 13–7. 2004. PMID 17642550. Αρχειοθετήθηκε από το πρωτότυπο στις 2009-07-03. https://web.archive.org/web/20090703155748/http://www.ijdvl.com/article.asp?issn=0378-6323%3Byear%3D2004%3Bvolume%3D70%3Bissue%3D1%3Bspage%3D13%3Bepage%3D17%3Baulast%3DSharma. Ανακτήθηκε στις 2017-02-07.
"hydroxyurea" στο Ιατρικό Λεξικό Dorland's
«Hydroxyurea arrests DNA replication by a mechanism that preserves basal dNTP pools». J. Biol. Chem. 279 (1): 223–30. January 2004. doi:10.1074/jbc.M303952200. PMID 14573610. Αρχειοθετήθηκε από το πρωτότυπο στις 2023-10-11. https://web.archive.org/web/20231011233407/https://www.jbc.org/article/S0021-9258(18)52807-6/fulltext. Ανακτήθηκε στις 2017-02-07.

who.int

«WHO Model List of Essential Medicines (19th List)» (PDF). World Health Organization. Απριλίου 2015. Ανακτήθηκε στις 8 Δεκεμβρίου 2016.

worldcat.org

Kettani, Tayeb; Cotton, Frédéric; Gulbis, Béatrice; Ferster, Alina; Kumps, Alain (2009-02-01). «Plasma hydroxyurea determined by gas chromatography-mass spectrometry». Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences 877 (4): 446–450. doi:10.1016/j.jchromb.2008.12.048. ISSN 1570-0232. PMID 19144580. https://www.ncbi.nlm.nih.gov/pubmed/19144580.